Vincerx Pharma (VINC) Earnings Date, Estimates & Call Transcripts

$0.76
-0.13 (-14.92%)
(As of 09:40 AM ET)

Earnings Summary

Upcoming
Earnings Date
May. 9Estimated
Actual EPS
(Mar. 29)
-$0.23 Missed By -$0.23
Skip Charts & View Estimated and Actual Earnings Data

VINC Earnings Estimates and Actuals by Quarter

The chart below shows up to four years of a company's earnings history. The dark blue line represents the company's actual earnings per share. The light blue area represents the range of Wall Street analysts' earnings estimates for each quarter.

VINC Estimated and Actual Revenue by Quarter

The chart below shows up to four years of a company's revenue history. The dark blue line represents the company's actual revenue. The light blue line represents the company's estimated revenue based on the consensus of Wall Street analysts for each quarter.

Vincerx Pharma Analyst EPS Estimates

QuarterNumber of EstimatesLow EstimateHigh EstimateAverage Estimate
Q1 20241($0.26)($0.26)($0.26)
Q2 20241($0.27)($0.27)($0.27)
Q3 20241($0.34)($0.34)($0.34)
Q4 20241($0.42)($0.42)($0.42)
FY 20244($1.29)($1.29)($1.29)

VINC Earnings Date and Information

Vincerx Pharma last announced its quarterly earnings data on March 29th, 2024. The reported ($0.23) earnings per share for the quarter. Vincerx Pharma has generated ($1.89) earnings per share over the last year (($1.89) diluted earnings per share). Earnings for Vincerx Pharma are expected to decrease in the coming year, from ($0.97) to ($1.11) per share. Vincerx Pharma has not formally confirmed its next earnings publication date, but the company's estimated earnings date is Thursday, May 9th, 2024 based off prior year's report dates.

Vincerx Pharma Earnings History by Quarter

DateQuarterConsensus EstimateReported EPSBeat/MissGAAP EPSRevenue EstimateActual RevenueCall Transcript
5/9/2024
Estimated)
------- 
3/29/2024Q4 2023-($0.23)($0.23)($0.23)--
11/14/2023Q3 2023($0.49)($0.46)+$0.03($0.46)--
8/7/2023Q2 2023($0.65)($0.52)+$0.13($0.52)--
5/11/2023Q1 2023($0.69)($0.68)+$0.01($0.68)--
3/28/2023Q4 2022($0.63)($0.65)($0.02)($0.65)--
11/10/2022Q3 2022($0.80)($0.80)-($0.80)--
8/11/2022Q2 2022($0.92)($0.88)+$0.04($0.88)--
5/12/2022Q1 2022($0.87)($0.79)+$0.08($0.79)--
3/29/2022Q4 2021($0.93)($0.85)+$0.08($1.39)--
11/12/2021Q3 2021($0.79)($1.02)($0.23)($0.65)--
8/12/2021Q2 2021($0.30)($0.12)+$0.18($0.12)--
5/16/2021Q1 2021($0.32)($0.46)($0.14)($0.46)--

Vincerx Pharma Earnings - Frequently Asked Questions

When is Vincerx Pharma's earnings date?

Vincerx Pharma has not confirmed its next earnings publication date, but the company's estimated earnings date is Thursday, May 9th, 2024 based off last year's report dates. Learn more on VINC's earnings history.

How much profit does Vincerx Pharma generate each year?

Vincerx Pharma (NASDAQ:VINC) has a recorded net income of -$40.16 million. VINC has generated -$1.89 earnings per share over the last four quarters.

What is Vincerx Pharma's EPS forecast for next year?

Vincerx Pharma's earnings are expected to decrease from ($0.97) per share to ($1.11) per share in the next year.


More Earnings Resources from MarketBeat

This page (NASDAQ:VINC) was last updated on 4/26/2024 by MarketBeat.com Staff

From Our Partners